IL155101A0 - Citrullimycines, a process for their production and their use as pharmaceuticals - Google Patents

Citrullimycines, a process for their production and their use as pharmaceuticals

Info

Publication number
IL155101A0
IL155101A0 IL15510101A IL15510101A IL155101A0 IL 155101 A0 IL155101 A0 IL 155101A0 IL 15510101 A IL15510101 A IL 15510101A IL 15510101 A IL15510101 A IL 15510101A IL 155101 A0 IL155101 A0 IL 155101A0
Authority
IL
Israel
Prior art keywords
citrullimycines
pharmaceuticals
production
Prior art date
Application number
IL15510101A
Other languages
English (en)
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of IL155101A0 publication Critical patent/IL155101A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/04Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
    • C07C275/06Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton
    • C07C275/16Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton being further substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00Preparation of nitrogen-containing organic compounds
    • C12P13/02Amides, e.g. chloramphenicol or polyamides; Imides or polyimides; Urethanes, i.e. compounds comprising N-C=O structural element or polyurethanes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465Streptomyces
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/886Streptomyces

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IL15510101A 2000-10-02 2001-09-27 Citrullimycines, a process for their production and their use as pharmaceuticals IL155101A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00121566A EP1193249A1 (de) 2000-10-02 2000-10-02 Citrullimycine, ein Verfahren zur Herstellung derselben, und deren Verwendung als Pharmazeutika
PCT/EP2001/011192 WO2002028824A1 (en) 2000-10-02 2001-09-27 Citrullimycines, a process for their production and their use as pharmaceuticals

Publications (1)

Publication Number Publication Date
IL155101A0 true IL155101A0 (en) 2003-10-31

Family

ID=8169998

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15510101A IL155101A0 (en) 2000-10-02 2001-09-27 Citrullimycines, a process for their production and their use as pharmaceuticals

Country Status (14)

Country Link
US (1) US6930130B2 (de)
EP (2) EP1193249A1 (de)
JP (1) JP2004510758A (de)
AR (1) AR032478A1 (de)
AT (1) ATE385494T1 (de)
AU (2) AU2002223566B2 (de)
CA (1) CA2424273A1 (de)
DE (1) DE60132703T2 (de)
DK (1) DK1324980T3 (de)
ES (1) ES2298279T3 (de)
IL (1) IL155101A0 (de)
MX (1) MXPA03002343A (de)
PT (1) PT1324980E (de)
WO (1) WO2002028824A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20040012396A (ko) * 2002-08-03 2004-02-11 대한민국(관리부서:농촌진흥청) 뇌신경성장인자 증강작용을 갖는 백강잠 추출물 및 이의활성성분을 함유하는 약학적 제제

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5252472A (en) * 1988-03-22 1993-10-12 Hoechst Aktiengesellschaft Process for the production of furans and lactones from streptomyces

Also Published As

Publication number Publication date
CA2424273A1 (en) 2002-04-11
JP2004510758A (ja) 2004-04-08
DK1324980T3 (da) 2008-05-13
EP1324980A1 (de) 2003-07-09
MXPA03002343A (es) 2003-06-30
AR032478A1 (es) 2003-11-12
US6930130B2 (en) 2005-08-16
EP1324980B1 (de) 2008-02-06
ES2298279T3 (es) 2008-05-16
AU2356602A (en) 2002-04-15
DE60132703T2 (de) 2009-02-05
US20020065316A1 (en) 2002-05-30
ATE385494T1 (de) 2008-02-15
WO2002028824A1 (en) 2002-04-11
EP1193249A1 (de) 2002-04-03
AU2002223566B2 (en) 2005-12-22
DE60132703D1 (de) 2008-03-20
PT1324980E (pt) 2008-04-01

Similar Documents

Publication Publication Date Title
HUP0300327A3 (en) Percyquinnin, a process for its production and its use as a pharmaceutical
IL152140A0 (en) Novel, slow-acting betamimetics, a method for their production and their use as medicaments
HUS1400005I1 (hu) Kinazolinszármazékok, elõállításuk, alkalmazásuk és ezeket tartalmazó gyógyszerek
HK1046681A1 (en) 6-alkenyl-, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use
AU6231801A (en) Acylphenyl urea derivatives, methods for the production thereof and use thereof as a medicament
AU2001262318A1 (en) Acylphenyl urea derivatives, methods for the production thereof and use thereof as a medicament
AU9181501A (en) Percarboxylated polysaccharides, and a process for their preparation
TWI319764B (en) Mercaptoacetylamide derivatives, a process for their preparation and their use
HUP0203875A3 (en) Microcapsule and process for production thereof
PL350190A1 (en) Epothilon derivatives, method for the production and the use thereof as pharmaceuticals
HK1046690A1 (en) Novel ribose-substituted aromatic amides, method for the production and use thereof as medicaments
HK1041026A1 (en) Vancoresmycin, a process for its production and its use as a pharmaceutical
IL152612A0 (en) Cyclipostins, a method for their production and the use of the same
HUP0204584A3 (en) Memnopeptides, a process for their preparation and their use
HUP0102370A3 (en) Mumbaistatin, a process for its production and its use as a pharmaceutical
AU2001262229A1 (en) Cyclipostins, a method for their production and the use of the same
AU2356602A (en) Citrullimycines, a process for their production and their use as pharmaceuticals
HUP0203593A3 (en) Amycomycin, a process for its production and its use as a pharmaceutical
EP1323707A4 (de) 4,8-dodecadiendinitril und verfahren zu dessen herstellung
HU0001178D0 (en) New propene-carbon acid-amidoxim derivatives, process for their production and medicaments containing the same
SI1294682T1 (en) Acylphenyl urea derivatives, methods for the production thereof and use thereof as a medicament
SI1100767T1 (en) Novel phenylethylamine derivatives, a method for the production thereof and their use as medicaments